Micléa Jean-Michel - Hôpital Necker-Enfants Malades

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 21 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Long-term Outcome of Imatinib 400 Mg Compared to Imatinib 600 Mg or Imatinib 400 Mg Daily in Combination with Cytarabine or Pegylated Interferon Alpha 2a for Chronic Myeloid Leukaemia: Results from the French SPIRIT Phase III Randomised Trial

Francois Guilhot,Françoise Rigal-Huguet,Joëlle Guilhot, Agnès-Paule Guerci-Bresler,Frédéric Maloisel,Delphine Rea,Valérie Coiteux,Martine Gardembas,Christian Berthou,Anne Vekhoff,Eric Jourdan,Marc Berger,Loïc Fouillard,Magda Alexis,Laurence Legros,Philippe Rousselot,Alain Delmer,Pascal Lenain,Martine Escoffre Barbe,Emmanuel Gyan,Claude-Eric Bulabois,Viviane Dubruille,Bertrand Joly, Bertrand Pollet,Pascale Cony-Makhoul,Hyacinthe Johnson-Ansah,Melanie Mercier,Denis Caillot,Aude Charbonnier,Jean-Jacques Kiladjian,Jacques Chapiro,Amélie Penot,Véronique Dorvaux,Iona Vaida,Alberto Santagostino,Lydia Roy,Hacene Zerazhi,Eric Deconinck,Herve Maisonneuve,Isabelle Plantier,Delphine Lebon,Yazid Arkam,Nathalie Cambier,Kamel Ghomari,Jean-Michel Miclea,Sylvie Glaisner,Jean-Michel Cayuela,Jean-Claude Chomel,Marc Muller,Ludovic Lhermitte,Marc Delord,Claude Preudhomme,Gabriel Etienne,François-Xavier Mahon,Franck- Emmanuel Nicolini

Leukemia（2021）

引用12浏览0WOSNATURE引用

Next-generation Sequencing for JAK2 Mutation Testing: Advantages and Pitfalls

Nabih Maslah,Emmanuelle Verger,Marie-Helene Schlageter,Jean-Michel Miclea,Jean-Jacques Kiladjian,Stephane Giraudier,Christine Chomienne,Bruno Cassinat

Annals of hematology（2018）

引用13浏览0WOS引用

Macrophage Activation Syndrome, First Toxoplasmosis Infection and T-Cell Lymphoma

Helene Salauen,Frederic Duriez, Zehaira Benseddik, Marina Mantzarides,Jean-Michel Miclea, Stephane Vignot

Hématologie/Hématologieno. 6 (2016): 439-444

引用0浏览0引用

0195: Identification of Patients (pts) with Chronic Myeloid Leukemia (CML) at High Risk of Artery Occlusive Events (AOE) During Treatment with the 2nd Generation Tyrosine Kinase Inhibitor (TKI) Nilotinib

Emmanuel Messas,Tristan Mirault,Emmanuel Raffoux,Jean Michel Miclea,Philippe Rousselot,Herve Dombret,Delphine Rea

Archives of cardiovascular diseases Supplements（2015）

引用0浏览0引用

A Nationwide Survey of the Use of Plerixafor in Patients with Lymphoid Malignancies Who Mobilize Poorly Demonstrates the Predominant Use of the “on‐demand” Scheme of Administration at French Autologous Hematopoietic Stem Cell Transplant Programs

Christian Chabannon,Fontanet Bijou,Jean-Michel Miclea,Noel Milpied,Jean-Marie Grouin,Mohamad Mohty

Transfusion（2015）

引用21浏览0WOS引用

Identification of Patients (pts) with Chronic Myeloid Leukemia (CML) at High Risk of Artery Occlusive Events (AOE) During Treatment with the 2nd Generation Tyrosine Kinase Inhibitor (TKI) Nilotinib, Using Risk Stratification for Cardiovascular Diseases (CVD)

Delphine Rea,Tristan Mirault,Emmanuel Raffoux,Jean-Michel Miclea,Philippe Rousselot,Herve Dombret,Emmanuel Messas

Bloodno. 21 (2013): 2726-2726

引用9浏览0引用

A Specific Time Course for Mobilization of Peripheral Blood CD34+ Cells after Plerixafor Injection in Very Poor Mobilizer Patients: Impact on the Timing of the Apheresis Procedure

Francois Lefrere,Laeticia Mauge,Delphine Rea,Jean-Antoine Ribeil,Liliane Dal Cortivo,Anne C. Brignier,Charbel Aoun,Jerome Larghero,Marina Cavazzana-Calvo,Jean-Michel Miclea

Transfusion（2012）

引用34浏览0WOS引用

Morgane Cheminant,Lionel Galicier,Josette Briere,David Boutboul,Jean-Michel Miclea,Marie-Dominique Venon,Marie Robin,Catherine Thieblemont,Pauline Brice

British journal of haematology（2012）

引用4浏览0WOS引用

Autologous Hematopoietic Stem Cell Collection And Transplantation In Acute Myeloid Leukemia Patients In Second Remission After Treatment With Fractionated Gentuzumab Ozogamycin

Delphine Rea,Emmanuel Raffoux,Anne Laure Taksin,Adrienne de Labarthe,Nicolas Boissel,Jean Michel Miclea,Sylvie Castaigne,Hervé Dombret

BLOOD（2006）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn